Commercializing IVD-Applicable Biomarkers: Best Practices and Pitfalls Handbook is now available

Aug 10, 2020

#TogetherAgainstCOVID19 – EuropaBio Interview with Finnish Bioindustries

Jun 25, 2020

Quest Diagnostics Acquires Blueprint Genetics to Broaden Access to Actionable Insights for Genetic and Rare Diseases

Jan 22, 2020

Blueprint Genetics expands in North America by building a new CLIA/CAP NGS facility in Seattle

May 24, 2019

DelSiTech Ltd Receives Significant Funding for Developing Long-Acting Injectables for contraceptives and HIV antivirals development by the Bill & Melinda Gates Foundation

May 21, 2019

Helsinki Biobank and Fimmic Introduce a Unique One Access Service for Biomedical Research

Oct 26, 2018

Life Science Mentors – Mentoring Service for Finnish Life Science Actors

Apr 11, 2018

Faron Pharmaceuticals Admission to AIM and first day of dealings £10 million fundraise to progress Phase III clinical trial

Nov 17, 2015

Faron Enters Agreement with Selexis SA to Progress Development of Novel Cancer Immunotherapy Clevegen

Nov 3, 2015